13 results · 32ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

Sourcerer

FDA 510(k)
FDA Class 2 ·Neurology

Millennium

FDA UDI
Avalign Technologies, Inc.·00190776378745·Pattie Tray Stainless Steel, for Modular Self-r...

ELMED

FDA UDI
ELMED INCORPORATED·00842180158993·MULTI - FLEX PATTIE TRAY, ATTACHES TO LONG OR S...

INSTRU-SAFE INSTRUMENT PROTECTION SYSTEM

FDA 510(k)
FDA Class 2 ·General Hospital

Quantra QPlus System

FDA 510(k)
FDA Class 2 ·Hematology

EVIDENT

FDA Adverse Event
Malfunction ·COVIDIEN MFG DC BOULDER·Product code NEY·January 14, 2019

EVIDENT

FDA Adverse Event
Injury ·COVIDIEN MFG DC BOULDER·Product code NEY·January 14, 2019

NUCLEUS 22 CHANNEL COCHLEAR IMPLANT SYSTEM

FDA Adverse Event
Injury ·COCHLEAR LTD.·Product code MCM·November 20, 2008

M SERIES

FDA Adverse Event
Malfunction ·ZOLL MEDICAL CORPORATION·Product code MKJ·August 9, 2011

HOMECHOICE PRO

FDA Adverse Event
Malfunction ·BAXTER HEALTHCARE - SINGAPORE·Product code FKX·July 22, 2013

PKG, GRASPER FORCEPS, ATRAUMATIC, P/N 0250080323. Laparoscopic Manual Instruments are intended for cutting, holding, grasping and manipulating of tissue, organs, organ areas and surgical auxiliaries such as suturing material. Some instruments have radio frequency (RF) ports which allow them to be used for electrosurgery. Laparoscopic surgical manual instruments are designed to be used endoscopically through cannulae to perform cutting, grasping, dissecting, retracting, and manipulating functions. This device does not sustain or support life.

FDA Enforcement
Class II ·Terminated·Stryker Endoscopy·December 24, 2014

Boston Scientific TELIGEN, Implantable Cardiac Defibrillator models E102, E110, the following models are not available in the US: models E103, E111, F102, F103, F110, F111. Sterilized using ethylene oxide. Product Usage: This family of implantable cardioverter defibrillators (ICDs) provide a variety of therapies including: -Ventricular tachyarrhythmia therapy, which is used to treat rhythms associated with sudden cardiac death such as VT and VF; -Bradycardia pacing, including adaptive rate pacing, to detect and treat bradyarrhythmias and to provide cardiac rate support after defibrillation therapy. Boston Scientific implantable cardioverter defibrillators (ICDs) are indicated to provide ventricular antitachycardia pacing (ATP) and ventricular defibrillation for automated treatment of life-threatening ventricular arrhythmias

FDA Enforcement
Class II ·Terminated·Boston Scientific CRM Corp·October 29, 2014

Alcon Custom Ophthalmic Surgical Procedure Packs

FDA Enforcement
Class II ·Terminated·Alcon Research, LLC·April 7, 2021